{
    "clinical_study": {
        "@rank": "14842", 
        "acronym": "Omega-3", 
        "arm_group": [
            {
                "arm_group_label": "O3FA", 
                "arm_group_type": "Experimental", 
                "description": "Omega 3 Fatty Acid 1200mg twice a day for 24 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "4 tablets twice a day for 24 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "60 patients receiving isotretinoin and 90 subjects receiving oral antibiotic therapy will be\n      recruited from the UCLA acne specialty clinic.  Subjects will be randomized in a 1:1 ratio\n      to receive placebo or omega-3 1200mg twice a day for 24 weeks."
        }, 
        "brief_title": "Effects of Omega-3 Fatty Acid Supplementation in Acne Patients", 
        "completion_date": {
            "#text": "January 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Acne", 
        "condition_browse": {
            "mesh_term": "Acne Vulgaris"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female above 18 years of age.\n\n          -  Moderate to severe disease at the baseline of the study identified by their\n             dermatologist.\n\n          -  Will start treatment with systemic therapy for acne in the form of either\n             isotretinoin or oral antibiotics.\n\n          -  Patients able and willing to comply with the procedures in the study protocol.\n\n        Exclusion Criteria:\n\n          -  Patients with history of taking omega-3 supplements for high triglyceride levels.\n\n          -  Patients taking medications for dyslipidemia, blood thinners, or high blood pressure\n             medication.\n\n          -  Patients with a history of adverse reaction to omega-3 fatty acid supplementation.\n\n          -  Unwilling to give inform consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764308", 
            "org_study_id": "O3FA"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "O3FA", 
                    "Placebo"
                ], 
                "description": "1200mg twice a day for 24 weeks", 
                "intervention_name": "Omega-3", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Omega-3 fatty acid; fish oil supplement; alpha-linolenic acid"
            }, 
            {
                "arm_group_label": [
                    "O3FA", 
                    "Placebo"
                ], 
                "description": "4 tablets twice a day for 24 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Sugar pill"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "acne; omega-3; isotretinoin; placebo", 
        "lastchanged_date": "January 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90095"
                }, 
                "name": "University of Califonia, Los Angeles Division of Dermatology"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Omega-3 Fatty Acid Supplementation in Acne Patients", 
        "overall_official": {
            "affiliation": "UCLA Division of Dermatology", 
            "last_name": "Christina N Kim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "In all study patients being treated for acne, lesion counts will be assessed and evaluated for any differences between patients on omega-3 fatty acid supplementation and not on supplementation.", 
            "measure": "Acne Lesion Count", 
            "safety_issue": "No", 
            "time_frame": "up to 24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764308"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of California, Los Angeles", 
            "investigator_full_name": "Christina Kim, MD", 
            "investigator_title": "Assistant Clinical Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of California, Los Angeles", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of California, Los Angeles", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}